EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, BFRG: Bullfrog AI Holdings Inc

17 Oct 25 19:55
LAST:

1.460

CHANGE:
 0.00		OPEN:
1.460		HIGH:
1.489		ASK:
0.000		VOLUME:
63.7K
CHG(%):
0.00		PREV:
1.470		LOW:
1.450		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Oct 251.4701.4801.4501.47069.7K
16 Oct 251.5401.5761.4501.470168.4K
15 Oct 251.5201.7001.4501.530434.9K
14 Oct 251.4601.5201.4301.470216K
13 Oct 251.3501.5071.3371.490203.3K
10 Oct 251.4301.4381.2801.320532K
09 Oct 251.5601.5701.4001.430438K
08 Oct 251.5102.0401.4911.5604.87M
07 Oct 251.5001.5201.4301.490114.7K
06 Oct 251.4401.5301.4401.500182.5K

COMPANY PROFILE

Name:Bullfrog AI Holdings Inc
About:Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform to analyze preclinical and clinical data for biotechnology and pharmaceutical companies, and other organizations. It also develops BF-222, a novel formulation of mebendazole , which is in the first phase for the treatment of Glioblastoma; BF-223, a novel prodrug of mebendazole, which is in the preclinical stage for the treatment of Glioblastoma; BF-114, which is in the discovery phase, to treat obesity and chronic liver diseases; and Modified HSV-1, which is in the discovery phase, for the treatment of modified colorectal cancer. The company has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. It also has a partnership with the Lieber Institute for Brain Development (LIBD) to enable the discovery and development of precision treatments for CNS disorders. The company was founded in 2017 and is headquartered in Gaithersburg, Maryland.
Sector:Healthcare
Address:325 Ellington Boulevard, Gaithersburg, MD, United States, 20878
Website:https://www.bullfrogai.com
CIK:0001829247
ISIN:US12021E1091
FIGI:BBG01BXY7SH6

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:1.491.8%
MA10:1.470.9%
MA20:1.450.6%
MA50:1.348.8%
MA100:1.460.3%
MA200:1.7620.7%
STO9:20.83
STO14:20.83
RSI14:55.42
WPR14:-37.50
MTM14:0.07
ROC14:0.05 
ATR:0.15 
Week High:1.7016.4%
Week Low:1.2814.1%
Month High:2.0439.7%
Month Low:1.2820.7%
Year High:4.84231.5%
Year Low:1.0933.9%
Volatility:37.38